Matthew Bardell
Matthew is Managing Director at nVentic and has worked in global supply chain since 2002, both in industry and as a consultant. He first got involved in inventory optimization while managing a global fresh produce supply chain in the retail sector. Since 2006 he has worked in consulting, helping clients develop and deliver supply chain, procurement and operational excellence strategy. Matthew has worked across a wide range of industries and geographies and has a Ph.D. from the University of Cambridge.
Matthew is Managing Director at nVentic and has worked in global supply chain since 2002, both in industry and as a consultant. He first got involved in inventory optimization while managing a global fresh produce supply chain in the retail sector. Since 2006 he has worked in consulting, helping clients develop and deliver supply chain, procurement and operational excellence strategy. Matthew has worked across a wide range of industries and geographies and has a Ph.D. from the University of Cambridge.
Articles: Matthew Bardell
The Dual Challenge of Unbalanced Inventory Growth & Medicine Shortages
Global / Several macro-trends affected the pharmaceutical industry in 2022, impacting its inventory position, writes Matthew Bardell, managing director of specialist inventory consultants nVentic. Bardell highlights findings in a recent report – including the fact that despite widely-reported medicine shortages, Big Pharma’s inventories grew significantly last year – and calls for a more optimised approach to inventory…
Latest Report
